| Introducing MASC: a movie for the assessment of social cognition I Dziobek, S Fleck, E Kalbe, K Rogers, J Hassenstab, M Brand, J Kessler, ... Journal of autism and developmental disorders 36, 623-636, 2006 | 1168 | 2006 |
| Tau and Aβ imaging, CSF measures, and cognition in Alzheimer’s disease MR Brier, B Gordon, K Friedrichsen, J McCarthy, A Stern, J Christensen, ... Science translational medicine 8 (338), 338ra66-338ra66, 2016 | 828 | 2016 |
| OASIS-3: longitudinal neuroimaging, clinical, and cognitive dataset for normal aging and Alzheimer disease PJ LaMontagne, TLS Benzinger, JC Morris, S Keefe, R Hornbeck, ... medrxiv, 2019.12. 13.19014902, 2019 | 796 | 2019 |
| Who cares? Revisiting empathy in Asperger syndrome K Rogers, I Dziobek, J Hassenstab, OT Wolf, A Convit Journal of autism and developmental disorders 37, 709-715, 2007 | 675 | 2007 |
| Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study SJB Vos, C Xiong, PJ Visser, MS Jasielec, J Hassenstab, EA Grant, ... The Lancet Neurology 12 (10), 957-965, 2013 | 651 | 2013 |
| Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study BA Gordon, TM Blazey, Y Su, A Hari-Raj, A Dincer, S Flores, ... The Lancet Neurology 17 (3), 241-250, 2018 | 604 | 2018 |
| A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nature medicine 26 (3), 398-407, 2020 | 528 | 2020 |
| Functional connectivity and graph theory in preclinical Alzheimer's disease MR Brier, JB Thomas, AM Fagan, J Hassenstab, DM Holtzman, ... Neurobiology of aging 35 (4), 757-768, 2014 | 426 | 2014 |
| Enabling technologies for personalized and precision medicine D Ho, SR Quake, ERB McCabe, WJ Chng, EK Chow, X Ding, BD Gelb, ... Trends in biotechnology 38 (5), 497-518, 2020 | 370 | 2020 |
| A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease S Salloway, M Farlow, E McDade, DB Clifford, G Wang, JJ Llibre-Guerra, ... Nature medicine 27 (7), 1187-1196, 2021 | 316 | 2021 |
| Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease E McDade, G Wang, BA Gordon, J Hassenstab, TLS Benzinger, V Buckles, ... Neurology 91 (14), e1295-e1306, 2018 | 304 | 2018 |
| Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease AJ Aschenbrenner, BA Gordon, TLS Benzinger, JC Morris, JJ Hassenstab Neurology 91 (9), e859-e866, 2018 | 299 | 2018 |
| The DIAN-TU Next Generation Alzheimer's prevention trial: adaptive design and disease progression model RJ Bateman, TL Benzinger, S Berry, DB Clifford, C Duggan, AM Fagan, ... Alzheimer's & Dementia 13 (1), 8-19, 2017 | 295 | 2017 |
| Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later CM Roe, AM Fagan, EA Grant, J Hassenstab, KL Moulder, ... Neurology 80 (19), 1784-1791, 2013 | 262 | 2013 |
| Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: a meta-analysis JE Baker, YY Lim, RH Pietrzak, J Hassenstab, PJ Snyder, CL Masters, ... Alzheimer's & dementia: Diagnosis, assessment & disease monitoring 6, 108-121, 2017 | 216 | 2017 |
| Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers BA Gordon, TM Blazey, J Christensen, A Dincer, S Flores, S Keefe, ... Brain 142 (4), 1063-1076, 2019 | 169 | 2019 |
| White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease MÁ Araque Caballero, M Suárez-Calvet, M Duering, N Franzmeier, ... Brain 141 (10), 3065-3080, 2018 | 160 | 2018 |
| Current advances in digital cognitive assessment for preclinical Alzheimer's disease F Öhman, J Hassenstab, D Berron, M Schöll, KV Papp Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13 (1 …, 2021 | 159 | 2021 |
| The adverse effects of reduced cerebral perfusion on cognition and brain structure in older adults with cardiovascular disease ML Alosco, J Gunstad, BA Jerskey, X Xu, US Clark, J Hassenstab, ... Brain and behavior 3 (6), 626-636, 2013 | 144 | 2013 |
| Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study E Morenas-Rodríguez, Y Li, B Nuscher, N Franzmeier, C Xiong, ... The Lancet Neurology 21 (4), 329-341, 2022 | 127 | 2022 |
Tammie L.S. Benzinger, MD, PhDProfessor of Radiology and Neurosurgery, Washington University School of Medicine in Saint LouisBestätigte E-Mail-Adresse bei wustl.edu
